Institutional Biosafety Committee (IBC) Meeting Minutes

In alignment with the National Institutes of Health (NIH) guidance on promoting transparency under the NIH guidelines (NOT-OD-25-082) for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, we provide public access to approved IBC meeting minutes when an IBC review is conducted on or after June 1, 2025.
IBC reviews occur only as needed, based on active research.

Meeting Minutes:

Looking to Participate in a Cancer Clinical Trial?

For more information on current clinical trials, talk with your physician or visit National Cancer Institute (NCI).